AVT02
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AVT02, covering 2019-01-18 to 2022-05-04. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetic, Efficacy, Safety, and Immunogenicity of AVT02 With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]